Leonovus Inc. (LTV.V)
| Previous Close | 0.0400 |
| Open | 0.0400 |
| Bid | 0.0450 x 0 |
| Ask | 0.0450 x 0 |
| Day's Range | 0.0400 - 0.0400 |
| 52 Week Range | 0.0200 - 0.0800 |
| Volume | |
| Avg. Volume | 519 |
| Market Cap | 836,040 |
| Beta (5Y Monthly) | 0.98 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0600 |
| Earnings Date | Apr 29, 2024 - May 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupLEONOVUS ANNOUNCES SALE OF ASSETS AND DEBT SETTLEMENT
Leonovus Inc. (TSXV: LTV) (the "Company" or "Leonovus") announces that it has signed a non-binding Letter of Intent ("LOI") to sell substantially all its software and patent assets to Cylentium Research Ltd. ("CRL"), a Delaware corporation, for $2,500,000 in an all-cash transaction (the "Transaction").
GlobeNewswireLeonovus Announces Releases 2022 Audit Results, Announces New CFO and Business Update
OTTAWA, May 01, 2023 (GLOBE NEWSWIRE) -- Leonovus Inc. ("Leonovus") (TSXV: LTV) announces the filing of its audited 2022 financial statements. Our MD&A contains a comprehensive discussion of Leonovus' financial position and results of operations and is available on SEDAR at www.sedar.com. Amounts are in Canadian dollars. The Company is pleased to announce that Board and Audit Committee has appointed Chris Carmichael as Chief Financial Officer. For over twenty years, Chris has held chief financia
- Baystreet
Stocks in play: Leonovus Inc.
Has changed its auditor from MNP LLP to Kenway Mack Slusarchuck Stewart LLP effective April 5. Leonovus ...
